de Néris Mélanie, Costanza Alessandra, Besson Marie, Greiner Christian, Prada Paco, Ambrosetti Julia
Service de psychiatrie de liaison et d'intervention de crise, HUG, 1211 Genève 14.
Département de psychiatrie, Faculté de médecine, Université de Genève, 1211 Genève 4.
Rev Med Suisse. 2020 Feb 12;16(681):314-317.
Suicide is a common cause of death in Switzerland. It often occurs during a period of crisis marked by a disruption of the subject's intrapsychic, interpersonal or social balance. The management of this crisis is crucial and essentially psychotherapeutic. Drug therapy may be necessary for the management of acute symptoms or for the prevention of long-term suicidal risk. Benzodiazepines and atypical antipsychotics are often used for acute symptoms such as anxiety or sleep disorders while other molecules are recognized in reducing long-term suicidal risk. Some disorders, such as borderline personality disorder, account for more frequent suicidal behaviors. The pharmacological management of these specific situations is discussed.
自杀是瑞士常见的死亡原因。它通常发生在一段危机时期，其特征是个体的内心、人际或社会平衡被打破。对这种危机的处理至关重要，且本质上是心理治疗性的。药物治疗对于急性症状的处理或长期自杀风险的预防可能是必要的。苯二氮䓬类药物和非典型抗精神病药物常用于治疗焦虑或睡眠障碍等急性症状，而其他药物则被认为可降低长期自杀风险。一些疾病，如边缘性人格障碍，会导致更频繁的自杀行为。本文讨论了这些特殊情况的药物治疗。
